| This week's sponsor is Roquette. | |  | Roquette - The Biological Choice
Sole custody of our supply chain ensures a safe, secure and reliable supply of quality raw materials and excipients. Trust Roquette for all your biopharma needs. Learn more. |
Featured Story Thursday, April 20, 2017  Despite reports that linked Novartis to cutting back on its cell therapy work, the Swiss major says it is going full steam ahead for its CAR-T research as a potential approval for its candidate appears on the horizon.
| This week's sponsor is Sensors Expo & Conference 2017. | |  | |
Top Stories Thursday, April 20, 2017 Two phase 3 trials of AbbVie’s PARP inhibitor veliparib have missed their primary endpoints. The studies set out to show that the addition of veliparib to chemotherapy improves outcomes in patients with non-small cell lung cancer or triple negative breast cancer but fell short of this goal. Wednesday, April 19, 2017 The European Commission has again sought to extinguish the United Kingdom’s lingering hopes of keeping the European Medicines Agency (EMA) in London after Brexit. Lead Brexiteer David Davis became the latest politician to claim London could retain the regulator earlier this week, only for a spokesperson for the commission to rubbish the idea. Thursday, April 20, 2017 Just as global security is starting to look a bit precarious, Tonix Pharmaceuticals has started recruiting military personnel into a phase 3 trial of its drug candidate for combat-related post-traumatic stress disorder (PTSD). Thursday, April 20, 2017 Eisai’s spinoff unit H3 Biomedicine has expanded its 2015 deal with Foundation Medicine as the pair look for new cancer drivers. Thursday, April 20, 2017 Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems. The deal gives J&J’s DePuy Synthes Products unit technology for creating personalized bioabsorbable implants designed to aid the healing of bones. Wednesday, April 19, 2017 An expert panel has released new guidelines for modern clinical trials, examining the importance of utilizing telehealth technologies in clinical studies. Wednesday, April 19, 2017 The FDA has twice rejected AstraZeneca’s application for a new drug to treat hyperkalemia because of manufacturing concerns. The reasons why became a little clearer Wednesday when the agency posted a document outlining the issues that have regulators furrowing their brows. | This week's sponsor is J.P. Morgan Private Bank. | |  | How Pre-Transaction Planning Can Maximize Your Wealth
You've worked hard to build a successful healthcare business. To reap the rewards of a sale, merger, recap or IPO, be sure you maximize the value of your equity interests with careful pre-transaction planning. Learn how J.P. Morgan Private Bank can help you protect your wealth. Read the article. |
| | | AbbVie's experimental pan-genotypic, ribavirin-free hep C combo therapy hit a 99% SVR 12-week rate in patients with compensated cirrhosis. Release George Church has been picked as one of Time's 100 most influential people for 2017. Time story Bicycle Therapeutics has hit a preclinical milestone with ThromboGenics after pushing a Bicycle candidate into preclinical development in diabetic macular edema. Statement | |
|
Resources Sponsored By: LMK Clinical Research Consulting Training is a vital component of workplace efficiency especially when it comes to one of the most important deliverables of a clinical trial – the Trial Master File (TMF). Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Presented By: Veeva Share your thoughts on the life sciences industry’s progress in reducing system and process complexity to improve study execution. The first 50 qualified respondents will receive a $10 Amazon gift card, as well as a $10 donation made to Doctors Without Borders in their name. Finish the survey today! Presented By: Enterprise Florida As life sciences companies decide to implement shared services, a major concern is real estate costs for a facility. Download this Whitepaper to learn why Florida is gaining traction as a prime location for shared services. | 
